sunscreen-Anthelios-SX.jpg The Food and Drug Administration (FDA) has approved a new sunscreen compound that protects against more harmful rays and lasts longer than products currently in the market. The new compound, ‘Ecamsule’, protects against both long-wave and shortwave ultraviolet light. The new product, will be sold under the name Anthelios SX and is expected to start retail sales this fall. According to the Academy of Dermatology, Anthelios SX can effectively avoid the incidence of skin cancer and wrinkles.

The facts on Athelios SX:

Anthelios SX contains three active ingredients: ecamsule, avobenzone and octocrylene.
The side effects associated with Athelios SX are acne, dermatitis, dry skin, eczema, abnormal redness, itching, skin discomfort and sunburn.
Prior to FDA approval the product was tested 2,500 patients, ranging in age from 6 months to 65 years.